CYTK FY 2020 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$56M+107.8% YoY

Gross Profit

-$41M-73.7% margin

Operating Income

-$94M-168.3% margin

Net Income

-$127M-228.0% margin

EPS (Diluted)

$-1.97

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

-$2M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$534M

Total Liabilities

$420M

Stockholders' Equity

$113M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$56M	$27M	+107.8%
Gross Profit	-$41M	-$59M	+30.6%
Operating Income	-$94M	-$99M	+5.0%
Net Income	-$127M	-$122M	-4.6%